C-Reactive Protein (CRP), Interferon Gamma-Inducible Protein 10 (IP-10), and Lipopolysaccharide (LPS) Are Associated with Risk of Tuberculosis after Initiation of Antiretroviral Therapy in Resource-Limited Settings
Mark W. Tenforde(Centers for Disease Control and Prevention), Amita Gupta(Johns Hopkins University), Breno Santos(Hospital Nossa Senhora da Conceição), Thomas Campbell(University of Colorado Anschutz Medical Campus), Richard D. Semba(Johns Hopkins University), Johnstone Kumwenda(Blantyre Institute for Community Ophthalmology), Ashwin Balagopal(Johns Hopkins University), David M. Asmuth(University of California, Davis), Nikhil Gupte(Johns Hopkins University), Patcharaphan Sugandhavesa(Chiang Mai University), Richard B. Pollard(University of California, Davis), David W. Dowdy(Johns Hopkins University), Robert C. Bollinger(Johns Hopkins University), Noluthando Mwelase(University of the Witwatersrand), Sandra Wagner Cardoso(Instituto Evandro Chagas), Cecilia Kanyama, Nagalingeswaran Kumarasamy(YR Gaitonde Centre for AIDS Research and Education), Jyoti Pawar(National AIDS Research Institute), James Hakim(University of Zimbabwe), Cynthia Riviere(Hôpital Necker-Enfants Malades), Javier R. Lama(Asociación Civil Impacta Salud y Educación), Sandy Pillay(Durban University of Technology)
Cited by 26
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k